PTKFF
Price
$0.09
Change
+$0.01 (+12.50%)
Updated
Jul 1 closing price
Capitalization
5.53B
SNPHY
Price
$11.74
Change
+$0.20 (+1.73%)
Updated
Jul 3 closing price
Capitalization
3.26B
Interact to see
Advertisement

PTKFF vs SNPHY

Header iconPTKFF vs SNPHY Comparison
Open Charts PTKFF vs SNPHYBanner chart's image
PT Kalba Farma TBK
Price$0.09
Change+$0.01 (+12.50%)
Volume$1K
Capitalization5.53B
Santen Pharmaceutical
Price$11.74
Change+$0.20 (+1.73%)
Volume$760
Capitalization3.26B
PTKFF vs SNPHY Comparison Chart in %
Loading...
PTKFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTKFF vs. SNPHY commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFF is a Hold and SNPHY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (PTKFF: $0.09 vs. SNPHY: $11.74)
Brand notoriety: PTKFF and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFF: 30% vs. SNPHY: 17%
Market capitalization -- PTKFF: $5.53B vs. SNPHY: $3.26B
PTKFF [@Pharmaceuticals: Major] is valued at $5.53B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFF’s FA Score shows that 2 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).

  • PTKFF’s FA Score: 2 green, 3 red.
  • SNPHY’s FA Score: 0 green, 5 red.
According to our system of comparison, PTKFF is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFF’s TA Score shows that 1 TA indicator(s) are bullish while SNPHY’s TA Score has 4 bullish TA indicator(s).

  • PTKFF’s TA Score: 1 bullish, 2 bearish.
  • SNPHY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SNPHY is a better buy in the short-term than PTKFF.

Price Growth

PTKFF (@Pharmaceuticals: Major) experienced а +23.77% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +4.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTKFF($5.53B) has a higher market cap than SNPHY($3.26B). PTKFF has higher P/E ratio than SNPHY: PTKFF (28.49) vs SNPHY (15.60). SNPHY YTD gains are higher at: 16.057 vs. PTKFF (-2.209). PTKFF has higher annual earnings (EBITDA): 4.85T vs. SNPHY (17.2B). PTKFF has more cash in the bank: 3.63T vs. SNPHY (62.3B). SNPHY has less debt than PTKFF: SNPHY (40.1B) vs PTKFF (889B). PTKFF has higher revenues than SNPHY: PTKFF (29.79T) vs SNPHY (270B).
PTKFFSNPHYPTKFF / SNPHY
Capitalization5.53B3.26B169%
EBITDA4.85T17.2B28,209%
Gain YTD-2.20916.057-14%
P/E Ratio28.4915.60183%
Revenue29.79T270B11,032%
Total Cash3.63T62.3B5,822%
Total Debt889B40.1B2,217%
FUNDAMENTALS RATINGS
PTKFF vs SNPHY: Fundamental Ratings
PTKFF
SNPHY
OUTLOOK RATING
1..100
5056
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
14100
PRICE GROWTH RATING
1..100
4446
P/E GROWTH RATING
1..100
7587
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTKFF's Valuation (24) in the null industry is somewhat better than the same rating for SNPHY (66). This means that PTKFF’s stock grew somewhat faster than SNPHY’s over the last 12 months.

PTKFF's Profit vs Risk Rating (100) in the null industry is in the same range as SNPHY (100). This means that PTKFF’s stock grew similarly to SNPHY’s over the last 12 months.

PTKFF's SMR Rating (14) in the null industry is significantly better than the same rating for SNPHY (100). This means that PTKFF’s stock grew significantly faster than SNPHY’s over the last 12 months.

PTKFF's Price Growth Rating (44) in the null industry is in the same range as SNPHY (46). This means that PTKFF’s stock grew similarly to SNPHY’s over the last 12 months.

PTKFF's P/E Growth Rating (75) in the null industry is in the same range as SNPHY (87). This means that PTKFF’s stock grew similarly to SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFFSNPHY
RSI
ODDS (%)
Bearish Trend 5 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
53%
Bullish Trend 5 days ago
68%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
MACD
ODDS (%)
Bullish Trend 5 days ago
51%
Bearish Trend 5 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
40%
Bullish Trend 5 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
44%
Bullish Trend 5 days ago
63%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
67%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
72%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
PTKFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTLLX29.030.35
+1.22%
Glenmede Disciplined US Growth Eq Ptf
ADCVX22.610.26
+1.16%
American Century Disciplined Growth A
AVEWX22.340.20
+0.90%
Ave Maria World Equity
VTSMX149.991.28
+0.86%
Vanguard Total Stock Mkt Idx Inv
SVFFX77.39-0.29
-0.37%
Smead Value I1

PTKFF and

Correlation & Price change

A.I.dvisor tells us that PTKFF and OTSKY have been poorly correlated (+1% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFF and OTSKY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFF
1D Price
Change %
PTKFF100%
N/A
OTSKY - PTKFF
1%
Poorly correlated
-1.50%
SNPHF - PTKFF
1%
Poorly correlated
N/A
RCDTF - PTKFF
0%
Poorly correlated
N/A
OTSKF - PTKFF
0%
Poorly correlated
N/A
SNPHY - PTKFF
-0%
Poorly correlated
+1.80%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and SNPHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
+1.80%
SNPHF - SNPHY
7%
Poorly correlated
N/A
RHHVF - SNPHY
7%
Poorly correlated
-2.91%
RHHBF - SNPHY
6%
Poorly correlated
N/A
RHHBY - SNPHY
5%
Poorly correlated
-1.73%
OTSKY - SNPHY
4%
Poorly correlated
-1.50%
More